Voy at-home test kit adverts banned over low testosterone claims

by | Nov 18, 2026 | Health

Voy at-home test kit adverts banned over low testosterone claims

The Advertising Standards Authority has prohibited five advertisements from online healthcare company Voy that promoted at-home testosterone blood tests, determining the marketing materials made false and misleading claims about the connection between everyday symptoms and low testosterone levels in men.

The banned content appeared across three poster advertisements and two paid Facebook campaigns. The ASA determined the adverts inappropriately suggested that common symptoms such as irritability and fatigue were strong indicators of testosterone deficiency. The watchdog noted that while some symptoms may be more closely linked to the condition, others lack specificity and should not be presented as reliable indicators of low testosterone when considered alone. One of the Facebook advertisements included the statement that low testosterone “sneaks up on 1 in 4 men over 30,” which the ASA found lacked supporting evidence.

Voy confirmed it had already withdrawn the advertisements during the investigation and stated it would not rerun them. The company’s chief medical officer asserted that all patient decisions at Voy are clinician-led and said the campaigns were developed to comply with UK advertising standards, while indicating the company maintains ongoing review of its marketing materials.

The NHS has indicated that while testosterone levels naturally decline with age in men, this decline is “unlikely” to cause problems in itself. The health authority acknowledges that testosterone deficiency in later life can sometimes contribute to symptoms including depression, reduced libido, erectile dysfunction, and other physical and emotional effects, though these symptoms are frequently unrelated to testosterone levels.

This ruling follows similar determinations in August against online providers BioID Health and Numan Digital Healthcare for comparable misleading claims in testosterone testing advertisements. The ASA has identified a broader pattern across the industry in which advertisers exploit anxieties surrounding sexual function, erectile issues, testosterone levels, and aging. The regulator confirmed that advertisements for testosterone tests and related services remain permissible provided claims are accurate and substantiated by evidence.

Article Attribution | Read More at Article Source

Article summary produced by Claude AI